This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Katsunori Kitamoto
Introduction
Katsunori Kitamoto is a notable inventor based in Kuwana, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzoazepine derivatives. His research focuses on compounds that exhibit V2 receptor agonistic activity, which has important medical applications.
Latest Patents
Katsunori Kitamoto holds a patent for a benzoazepine derivative and its medical use. This patent describes a compound that provides a pharmaceutical composition containing an active ingredient represented by a specific general formula. The compound is designed to have pharmacological effects, particularly in relation to V2 receptor activity.
Career Highlights
Kitamoto is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has been instrumental in advancing pharmaceutical research. His work has led to the development of innovative compounds that have the potential to improve medical treatments.
Collaborations
He has collaborated with notable colleagues, including Nobuyoshi Kasugai and Hiroyo Kataoka, to further enhance the research and development of pharmaceutical innovations.
Conclusion
Katsunori Kitamoto's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile